GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Wuhan Keqian Biology Co Ltd (SHSE:688526) » Definitions » Price-to-Owner-Earnings

Wuhan Keqian Biology Co (SHSE:688526) Price-to-Owner-Earnings : 34.44 (As of Jun. 23, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Wuhan Keqian Biology Co Price-to-Owner-Earnings?

As of today (2024-06-23), Wuhan Keqian Biology Co's share price is ¥15.50. Wuhan Keqian Biology Co's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥0.45. It's Price-to-Owner-Earnings for today is 34.44.


The historical rank and industry rank for Wuhan Keqian Biology Co's Price-to-Owner-Earnings or its related term are showing as below:

SHSE:688526' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 23.59   Med: 31.37   Max: 48.9
Current: 34.52

During the past 8 years, the highest Price-to-Owner-Earnings of Wuhan Keqian Biology Co was 48.90. The lowest was 23.59. And the median was 31.37.


SHSE:688526's Price-to-Owner-Earnings is ranked worse than
50.6% of 166 companies
in the Biotechnology industry
Industry Median: 33.85 vs SHSE:688526: 34.52

As of today (2024-06-23), Wuhan Keqian Biology Co's share price is ¥15.50. Wuhan Keqian Biology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.74. Therefore, Wuhan Keqian Biology Co's PE Ratio for today is 20.95.

As of today (2024-06-23), Wuhan Keqian Biology Co's share price is ¥15.50. Wuhan Keqian Biology Co's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.93. Therefore, Wuhan Keqian Biology Co's PE Ratio without NRI for today is 16.61.

During the past 8 years, Wuhan Keqian Biology Co's highest PE Ratio without NRI was 48.39. The lowest was 14.09. And the median was 23.25.


Wuhan Keqian Biology Co Price-to-Owner-Earnings Historical Data

The historical data trend for Wuhan Keqian Biology Co's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Keqian Biology Co Price-to-Owner-Earnings Chart

Wuhan Keqian Biology Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - 44.97 - - 36.79

Wuhan Keqian Biology Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 31.39 26.72 36.79 38.91

Competitive Comparison of Wuhan Keqian Biology Co's Price-to-Owner-Earnings

For the Biotechnology subindustry, Wuhan Keqian Biology Co's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Keqian Biology Co's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan Keqian Biology Co's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Wuhan Keqian Biology Co's Price-to-Owner-Earnings falls into.



Wuhan Keqian Biology Co Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Wuhan Keqian Biology Co's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=15.50/0.45
=34.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Keqian Biology Co  (SHSE:688526) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Wuhan Keqian Biology Co Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Wuhan Keqian Biology Co's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Keqian Biology Co (SHSE:688526) Business Description

Traded in Other Exchanges
N/A
Address
No. 419, Gaoxin 2nd Road, Donghu New Technology Development Zone, Hubei Province, Wuhan, CHN, 430073
Wuhan Keqian Biology Co Ltd is engaged in research and development, production, sales and animal epidemic prevention technical services of veterinary biological products. The company's products include Combination plan; Vaccine for swine; Poultry vaccine; Pet vaccine; and Diagnostic reagent.
Executives
Hao Gen Xi Core technical personnel
Zhang Hua Wei Core technical personnel
Zhou Ming Guang Core technical personnel
Zou Tian Tian senior management
Xu Gao Yuan Director
Chen Guan Ping Director

Wuhan Keqian Biology Co (SHSE:688526) Headlines

No Headlines